Clinical Oral Investigations

, Volume 16, Issue 2, pp 551–558 | Cite as

Oral soft tissue alterations in patients with neurofibromatosis

  • Eeva-Mari Jouhilahti
  • Vivian Visnapuu
  • Tero Soukka
  • Heikki Aho
  • Sirkku Peltonen
  • Risto-Pekka Happonen
  • Juha PeltonenEmail author
Original Article


Our aim was to characterize the type and frequency of oral soft tissue alterations in neurofibromatosis. A total of 103 patients with neurofibromatosis 1 (NF1) and three patients with neurofibromatosis 2 (NF2) were clinically evaluated for their oral soft tissue alterations. Disturbing growths were removed from nine patients with NF1 and from one patient with NF2. The specimens were analyzed using routine histological methods and with immunohistochemistry using antibodies to S100, type IV collagen, CD34, neurofilament, and neuron-specific tubulin (TUBB3). Alterations including oral tumors, overgrowths of gingival soft tissue, and enlarged papillae of the tongue were discovered in 74% of NF1 patients. The results showed that three tumors clinically classified as plexiform neurofibromas and five out of six discrete mucosal tumors displayed histology and immunohistology consistent with that of neurofibroma. The histology of one palatal lesion resembled that of a scar, and the lesion removed from the patient with NF2 was classified as an amyloid tumor. To conclude, oral soft tissue growths are common findings in NF1, but most lesions do not require treatment and the patients may even not be aware of these alterations. Collagen IV, S100, and CD34 are useful biomarkers in the analysis of NF1-related oral soft tissue tumors. The clinicians should recognize that oral soft tissue alterations are relatively common in NF1. Some of the growths are disturbing, and plexiform neurofibromas may bear a risk of malignant transformation.


Mouth Schwann cell Tumor syndrome Dentistry 



Academy of Finland, Turku University Foundation, Southwest Finland Hospital District and Turku Graduate School of Biomedical Sciences

Conflict of interest

The authors declare that they have no conflict of interest.


  1. 1.
    Huson SM (2008) The neurofibromatoses: classification, clinical features and genetic counselling. In: Kaufmann D (ed) Neurofibromatoses. Karger, Basel, pp 1–20CrossRefGoogle Scholar
  2. 2.
    Lammert M, Friedman J, Kluwe L, Mautner VF (2005) Prevalence of neurofibromatosis 1 in German children at elementary school enrollment. Arch Dermatol 141:71–74PubMedCrossRefGoogle Scholar
  3. 3.
    Bollag G, McCormick F, Clark R (1993) Characterization of full-length neurofibromin: tubulin inhibits Ras GAP activity. EMBO J 12:1923–1927PubMedGoogle Scholar
  4. 4.
    Stumpf D, Alksne J, Annegers J et al (1988) Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference. Arch Neurol 45:575–578CrossRefGoogle Scholar
  5. 5.
    Evans D (2009) Neurofibromatosis 2 [bilateral acoustic neurofibromatosis, central neurofibromatosis, NF2, neurofibromatosis type II]. Genet Med 11:599–610PubMedCrossRefGoogle Scholar
  6. 6.
    Depprich R, Singh DD, Reinecke P, Kübler NR, Handshel J (2009) Solitary submucous neurofibroma of the mandible: review of the literature and report of a rare case. Head Face Med 5:24PubMedCrossRefGoogle Scholar
  7. 7.
    do Nascimento G, de Albuquerque Pires Rocha D, Galvão H, de Lisboa Lopes Costa A, de Souza LB (2010) A 38-year review of oral schwannomas and neurofibromas in a Brazilian population: clinical, histopathological and immunohistochemical study. Clin Oral Investig. doi: 10.1007/s00784-010-0389-7 PubMedGoogle Scholar
  8. 8.
    Shapiro SD, Abramovitch K, Van Dis ML, Skoczylas LJ, Langlais RP, Young RS, Riccardi VM (1984) Neurofibromatosis: oral and radiographic manifestations. Oral Surg Oral Med Oral Pathol 58:493–498PubMedCrossRefGoogle Scholar
  9. 9.
    D'Ambrosio J, Langlais R, Young R (1988) Jaw and skull changes in neurofibromatosis. Oral Surg Oral Med Oral Pathol 66:391–396PubMedCrossRefGoogle Scholar
  10. 10.
    Powell CA, Stanley CM, Bannister S, McDonnell HT, Moritz AJ, Deas DE (2006) Palatal neurofibroma associated with localized periodontitis. J Periodontol 77:310–315PubMedCrossRefGoogle Scholar
  11. 11.
    Lassmann H, Jurecka W, Lassmann G, Gebhart W, Matras H, Watzek G (1977) Different types of benign nerve sheath tumors. Light microscopy, electron microscopy and autoradiography. Virchows Arch A Pathol Anat Histol 375:197–210PubMedCrossRefGoogle Scholar
  12. 12.
    Peltonen J, Jaakkola S, Lebwohl M, Renvall S, Risteli L, Virtanen I, Uitto J (1988) Cellular differentiation and expression of matrix genes in type 1 neurofibromatosis. Lab Invest 59:760–771PubMedGoogle Scholar
  13. 13.
    Pummi K, Aho H, Laato M, Peltonen J, Peltonen S (2006) Tight junction proteins and perineurial cells in neurofibromas. J Histochem Cytochem 54:53–61PubMedCrossRefGoogle Scholar
  14. 14.
    Riccardi V (2007) The genetic predisposition to and histogenesis of neurofibromas and neurofibrosarcoma in neurofibromatosis type 1. Neurosurg Focus 22:E3PubMedCrossRefGoogle Scholar
  15. 15.
    Hassell D, Bancroft L, Kransdorf M, Peterson JJ, Berquist TH, Murphey MD, Fanburg-Smith JC (2008) Imaging appearance of diffuse neurofibroma. AJR Am J Roentgenol 190:582–588PubMedCrossRefGoogle Scholar
  16. 16.
    Majoie C, Hulsmans F, Castelijns J, Sie LH, Walter A, Valk J, Albrecht KW (1999) Primary nerve-sheath tumours of the trigeminal nerve: clinical and MRI findings. Neuroradiology 41:100–108PubMedCrossRefGoogle Scholar
  17. 17.
    Visnapuu V, Peltonen S, Ellilä T, Kerosuo E, Väänänen K, Happonen RP, Peltonen J (2007) Periapical cemental dysplasia is common in women with NF1. Eur J Med Genet 50:274–280PubMedCrossRefGoogle Scholar
  18. 18.
    Visnapuu V, Pienihäkkinen K, Peltonen S, Happonen RP, Peltonen J (2011) Neurofibromatosis 1 and dental caries. Clin Oral Investig 15:119–121PubMedCrossRefGoogle Scholar
  19. 19.
    Jouhilahti E, Peltonen S, Peltonen J (2008) Class III beta-tubulin is a component of the mitotic spindle in multiple cell types. J Histochem Cytochem 56:1113–1119PubMedCrossRefGoogle Scholar
  20. 20.
    Chaubal A, Paetau A, Zoltick P, Miettinen M (1994) CD34 immunoreactivity in nervous system tumors. Acta Neuropathol 88:454–458PubMedCrossRefGoogle Scholar
  21. 21.
    Jaakkola S, Muona P, James W, Hannuksela M, Karvonen J, Peltonen J, Uitto J (1990) Segmental neurofibromatosis: immunocytochemical analysis of cutaneous lesions. J Am Acad Dermatol 22:617–621PubMedCrossRefGoogle Scholar
  22. 22.
    Baden E, Jones J, Khedekar R, Burns WA (1984) Neurofibromatosis of the tongue: a light and electronmicroscopic study with review of the literature from 1849 to 1981. J Oral Med 39:157–164PubMedGoogle Scholar
  23. 23.
    Friedrich R, Giese M, Schmelzle R, Mautner VF, Scheuer HA (2003) Jaw malformations plus displacement and numerical aberrations of teeth in neurofibromatosis type 1: a descriptive analysis of 48 patients based on panoramic radiographs and oral findings. J Craniomaxillofac Surg 31:1–9PubMedCrossRefGoogle Scholar
  24. 24.
    Cunha K, Barboza E, Dias E, Oliveira FM (2004) Neurofibromatosis type I with periodontal manifestation. A case report and literature review. Br Dent J 196:457–460PubMedCrossRefGoogle Scholar
  25. 25.
    García de Marcos J, Dean Ferrer A, Alamillos Granados F et al (2007) Gingival neurofibroma in a neurofibromatosis type 1 patient. Med Oral Patol Oral Cir Bucal 12:E287–E291PubMedGoogle Scholar
  26. 26.
    Alivuotila L, Hakokari J, Visnapuu V et al (2010) Speech characteristics in neurofibromatosis type 1. Am J Med Genet A 152A:42–51PubMedCrossRefGoogle Scholar
  27. 27.
    Rautava J, Luukkaa M, Heikinheimo K, Alin J, Grenman R, Happonen RP (2007) Squamous cell carcinomas arising from different types of oral epithelia differ in their tumor and patient characteristics and survival. Oral Oncol 43:911–919PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • Eeva-Mari Jouhilahti
    • 1
  • Vivian Visnapuu
    • 1
    • 2
  • Tero Soukka
    • 2
  • Heikki Aho
    • 3
  • Sirkku Peltonen
    • 4
  • Risto-Pekka Happonen
    • 2
  • Juha Peltonen
    • 1
    • 5
    Email author
  1. 1.Institute of Biomedicine, Department of Cell Biology and AnatomyUniversity of TurkuTurkuFinland
  2. 2.Department of Oral and Maxillofacial SurgeryUniversity of Turku and Turku University HospitalTurkuFinland
  3. 3.Department of PathologyTurku University HospitalTurkuFinland
  4. 4.Department of DermatologyUniversity of Turku and Turku University HospitalTurkuFinland
  5. 5.Department of Cell Biology and Anatomy, Institute of BiomedicineUniversity of TurkuTurkuFinland

Personalised recommendations